Triad Isotopes
Pharmaceutical ManufacturingPennsylvania, United States501-1000 Employees
Triad Isotopes operates as a nuclear pharmacy within the pharmaceutical manufacturing sector, building a nationwide network of facilities that prepare PET radiopharmaceutical doses for clinical use. The network comprises more than 60 locations and four cyclotrons, serving hospitals and nuclear medicine providers to diagnose and treat patients, particularly in cardiac and oncologic care, with millions of patients treated annually. The company is described as the second-largest and fastest-growing nuclear pharmacy chain in the United States. It maintains an open formulary approach that gives customers access to all radiopharmaceuticals, enabling formulation selection tailored to patient needs and to national purchasing organizations and regional healthcare systems. Triad also supports education and research through its Institute of Learning, which brings together clinicians, technologists and nuclear pharmacists with extensive SPECT and PET/CT expertise. The organization is headquartered in Orlando, Florida, and lists a mailing address in Yardley, Pennsylvania, reflecting its national footprint.